0
Orphan Designations
2
FDA Approvals
Latest: SILVER SULFADIAZINE (1985)
0
Active Trials
173 recruiting
1
Rare Diseases
across 4 areas
0
News (30d)
Quiet
Ascend Laboratories, LLC is a company with 0 orphan drug designations across 1 rare disease, including 2 FDA-approved therapies.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| hemophilia A | - | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
0
overlap in 2+ diseases
0/1
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
0
overlap in 2+ diseases
0/1
candidate diseases
0
avg importance: 0
0
affecting portfolio